While cancer cases are rising at an alarming rate every year, early detection of the cancers is still a relatively difficult phenomenon. In fact, much of the morbidity and mortality in human cancer is related to the late diagnosis of this disease, where surgical and pharmacologic therapies are less effective. A recent study conducted at the Johns Hopkins Kimmel Cancer Center, reported a test that uses small amounts of cancer specific DNA in blood to detect early stage cancers.